According to a recent LinkedIn post from Open Medical, the company has been shortlisted as a finalist at the Medilink North of England Healthcare Business Awards, in conjunction with the Lancashire and South Cumbria Integrated Care Board. The recognition appears linked to a regional skin cancer pathway transformation that uses Open Medical’s Pathpoint platform and a Centralised Virtual Triage care model.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights reported operational metrics from this deployment, including 99.2% Faster Diagnosis Standard compliance, a fourfold increase in consultant capacity, development of digital locum capabilities, and projected savings of over £1.7 million for the region. For investors, these figures may indicate strong proof-of-concept traction for Pathpoint in oncology pathways, potentially strengthening Open Medical’s positioning in NHS partnerships and supporting future revenue opportunities in wider healthcare digitisation.